REG - Spire Healthcare Grp - Annual Financial Report

Spire HealthcareAnnouncement

03/04/2023 12:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230403:nRSC1758Va&default-theme=true

RNS Number : 1758V  Spire Healthcare Group PLC  03 April 2023

 

Spire Healthcare Group plc

 

3 April 2023

 

2022 Annual Report and 2023 Notice of Annual General Meeting

Spire Healthcare Group plc (the "Company") released its preliminary
announcement of its annual results for the year ended 31 December 2022
("Preliminary Announcement") on Thursday, 2 March 2023.

 

Further to that Preliminary Announcement, the Company confirms that its Annual
Report and Accounts for the year ended 31 December 2022 ("2022 Annual
Report"), 2023 Notice of Annual General Meeting and Form of Proxy have now
been published. Printed copies have been posted to shareholders who have
requested hard copies.

 

The following documents are available on the Company's website:

 

2022 Annual Report:               www.spirehealthcare.com/AR2022

2023 Notice of Meeting:         www.spirehealthcare.com/Notice2023

 

In accordance with the Financial Conduct Authority's ("FCA") Listing Rule
9.6.1 R, the Company will submit its 2022 Annual Report and other shareholder
documents to the National Storage Mechanism. These documents should be
available for inspection within two working days at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

 

In accordance with the FCA's Disclosure and Transparency Rules ("DTRs") the
regulated information required to be communicated under DTR 6.3.5R(1A) is
available in unedited full text within the 2022 Annual Report which will be
available both on the National Storage Mechanism and on the Company's website
www.spirehealthcare.com.

 

Arrangements for the Annual General Meeting

The Annual General Meeting of the Company will be held at 11.00am on Thursday,
11 May 2023 at 3 Dorset Rise, London EC4Y 8EN (the "2023 AGM").

 

The Company expects that shareholders will be able to attend the 2023 AGM in
person but shareholders are asked to monitor the Company's website for any
changes in requirements on attending the meeting.

 

The Board always welcomes questions from shareholders and we request that
these are submitted by e-mail to companysecretary@spirehealthcare.com
(mailto:companysecretary@spirehealthcare.com) . Answers to questions received
will be placed on the Company's website ahead of the meeting.

 

Details of the resolutions to be proposed at the 2023 AGM are set out in the
2023 Notice of Meeting. The voting results of all resolutions put before the
2023 AGM will be announced to the market following the meeting.

 

 

Enquiries:

Philip Davies

Company Secretary

Tel: 07803 508348

 

About Spire Healthcare

Spire Healthcare is a leading independent healthcare group in the United
Kingdom, with 39 hospitals and 33 clinics, medical centres and consulting
rooms across England, Wales and Scotland. It operates a network of private GPs
and provides occupational health services to over 700 corporate clients.

Working in partnership with over 8,760 experienced consultants, Spire
Healthcare delivered tailored, personalised care to approximately 926,500
inpatients, outpatients and day-case patients in 2022, and is the leading
private provider, by volume, of knee and hip operations in the United Kingdom.
The Group's well-located and scalable hospitals have delivered successful and
award-winning clinical outcomes, positioning the Group well with patients,
consultants, the NHS, GPs and Private Medical Insurance (PMI) providers. 98%
of Spire Healthcare's inspected hospitals and clinics are rated 'Good',
'Outstanding' by the CQC or the equivalent in Scotland and Wales.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ACSSSEFFDEDSESL